{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Collaborative Deprescribing in Borderline Personality Disorder: A Narrative Review

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Assess medication management in patients with borderline personality disorder (BPD)
  2. Evaluate the role of deprescribing as an active intervention in patients with BPD treated with polypharmacy
Price: $12.95

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: HRP0319
Published: Mar/Apr 2019
Expires: 3/30/2021
Passing Score: 7/10 (70%)
Authors: Sarah K. Fineberg, MD, PhD, Swapnil Gupta, MBBS, MD and Jacob Leavitt, BA
Categories: Management , Psychiatric